HABIT-ILE + FST for Children with SMA

This study is looking at how well an intensive motor skill program called HABIT-ILE combined with functional strength training (FST) works for children with Spinal Muscular Atrophy (SMA). This program helps with both arm and leg movements and strengthening. You might be able to join if you are 5-17 years old, have a confirmed SMA diagnosis, can understand English, and have been on a stable dose of disease-modifying therapy (DMT) for at least six months. The study will measure success by looking at changes in your motor skills using a tool called the Hammersmith Functional Motor Scale - Expanded (HFMSE). The study is currently unclear on its recruitment status and plans to enroll 20 participants.

Study design
This is a single-arm pilot study, meaning all 20 participants will receive the same intervention. The study does not specify a phase.
What's involved
Participants will attend a summer camp for 6 hours a day over 3 weeks, totaling 90 hours of training. You will also complete assessments at the beginning, immediately after the intervention, and 3 months later.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 3 months after the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07488338

HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness

Recruiting
NAAges 5–17InterventionalTreatment
Teachers College, Columbia University
~20 participants
Updated 2026-03-23 on ClinicalTrials.gov
What's tested:Combined Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) + functional strength training (FST)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Hammersmith Functional Motor Scale - Expanded (HFMSE)
Measured over 3 assessments: Baseline, immediately after the intervention, 3 months follow-up
Spinal Muscular Atrophy (SMA)
1 sites across 1 states
New York1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Have a confirmed SMA diagnosis
Be 5-17 years old
Complete all pre- and post-intervention assessments
Understand and speak English
Follow instructions without major cognitive or behavioral issues
Have received a stable disease-modifying therapy (DMT) dose for ≥6 months
Be classified as a sitter or walker (SMA type 2 or 3) with supported standing ability (score ≥1 on Item 18 of the HFMSE) without KAFOs, AFOs, or external standing devices

Exclusion

Orthopedic surgery within the past year
New pharmaceutical treatment during the study
Concurrent participation in another clinical trial
  • Hammersmith Functional Motor Scale - Expanded (HFMSE)3 assessments: Baseline, immediately after the intervention, 3 months follow-up

    Gross motor function measure; range: 0 to 66; higher scores indicate better motor function